Biotech ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers By Radhika ShahFebruary 15, 2023 Last week, President and Co-Founder Sumayah Jamhal presented her company, ENB Therapeutics, at the 2023 Immuno-Oncology 360 Degree Conference in… Read More
